Haidari, F., Abiri, B., Haghighizadeh, M
Gently shake to ensure the complete the solubilization, then administer the solution thus obtained by slow intravenous route
Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain
R NAT2 polymorphisms alter catalytic activity primarily through effects on protein stability and degradation rates rather than changes to the active site itself (slow acetylator alleles produce unstable protein that is rapidly ubiquitinated and degraded)
VSMCs, vascular smooth muscle cells
f , HCC-1806 cells were treated with BSO (100 M) for 24 h, and relative GSH levels were determined